Technological difficulties in ghrelin and obestatin assays

Endokrynologia Polska

Volumn 62, Issue 4, 2011, Pages 336-339

  Kosowicz, Jerzy ^a   Baumann Antczak, Aleksandra ^a   Zamysołwska, Hanna ^a   Sowinśki, Jerzy ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Assays; Ghrelin; Obestatin; Technological difficulties

Indexed keywords

GASTROINTESTINAL POLYPEPTIDE; GHRELIN; ISOPROTEIN; NEUROPEPTIDE; OBESTATIN;

BIOLOGICAL ACTIVITY; BIOTECHNOLOGY; BLOOD BRAIN BARRIER; CLINICAL EVALUATION; ENZYMATIC DEGRADATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; PLASMA; RADIOIMMUNOASSAY; REVIEW; TEMPERATURE;

ANIMALS; BLOOD-BRAIN BARRIER; GHRELIN; HUMANS; RADIOIMMUNOASSAY;

EID: 80052578838     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Kojima M., Hosoda H., Date Y., Nakazato M., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660. (Pubitemid 129516334)
2. Kojima M., Kangawa K. Structure and function of ghrelin. Results Probl Cell Differ2008; 46: 89-115.
3. Suzuki K., Simpson K.A., Minnion J.S., Shillito J.C., Bloom S.R. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J 2010; 57: 359-372.
4. Masuda Y., Tanaka T., Inomata N. et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Bioph Res Co 2000; 276: 905-908.
5. Asakawa A., Inui A., Kaga T. et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001; 120: 337-345. (Pubitemid 32149296)
6. Cummings D.E., Weigle D.S., Scott Frayo R. et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. NEJM 2002; 346: 1623-1630. (Pubitemid 34755670)
7. Zhang J.V., Ren P.G., Avsian-Kretchmer O. et al. Obestatin, a peptide encoded by ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310: 996-999. (Pubitemid 41611907)
8. Nogueiras R., Pfluger P., Tovar S. et al. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 2007; 148: 21-26. (Pubitemid 46021434)
9. Yamamoto D., Ikeshita N., Daito R. et al. Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats. Regul Peptides 2007; 1: 141-144. (Pubitemid 46054226)
10. Gourcerol G., Coskun T., Craft L.S. et al. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents. Obesity 2007; 15: 2643-2652.
11. Gourcerol G., Tache Y. Obestatin - A ghrelin- Associated peptide that does not hold its promise to suppress food intake and motility. Neurogastroent Motil 2007; 19: 161-165. (Pubitemid 46239426)
12. Mondal M., Toshinai K., Ueno H., Koshinaka K., Nakazato M. Characterization of obestatin in rat and human stomach and plasma, and its lack of acute effect on feeding behavior in rodents. J Endocrinol 2008; 198: 339-346.
13. Dhillo W.S. Appetite regulation: An overview. Thyroid 2007; 17: 433-445. (Pubitemid 46878846)
14. Suzuki K., Simpson K.A., Minnion J.S., Shillito J.C., Bloom S.R. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J 2010; 57: 359-372.
15. Jaskuła M., Waśko R., Komarowska H., Dziubandowska A., Sowiński J. Serum ghrelin levels and disturbances of the lipid profile in patients with acromegaly. Neuro Endocrinol Lett 2009; 30: 245-255.
16. Kosowicz J., Baumann-Antczak A., Ruchała M., Gryczyńska M., Gurgul E., Sowiński J. Thyroid hormones affect plasma ghrelin and obestatin levels. Horm Metab Res 2011; 43: 121-125.
17. Komarowska H., Waśko R., Iwanik K. et al. Ghrelin ovarian cell expression in patients with polycystic ovary syndrome: An immunohistochemical evaluation. Horm Metab Res 2006; 38: 783-788. (Pubitemid 46051497)
18. Ruchała M. Ghrelina i somatostatyna jako modulatory sekrecji hormonów tarczycy: badania doświadczalne in vivo i in vitro oraz wynikaja̧ce z nich implikacje kliniczne. Wydawnictwo Naukowe Uniwersytetu Medycznego im. K. Marcinkowskiego Poznań 2007.
19. Waśko R., Jaskuła M., Komarowska H., Zamysłowska H., Sowiński J., Waligórska-Stachura J. Ghrelin concentration in acromegalic patients in relation to the administrated therapy. Neuro Endocrinol Lett 2006; 27: 162-168. (Pubitemid 43970787)
20. Waśko R., Koamrowska H., Warenik-Szymankiewicz A., Sowiński J. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome. Horm Metab Res 2004; 36: 170-173. (Pubitemid 38510038)
21. Otto B., Cuntz U., Fruehauf E. et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2006; 145: 669-673.
22. Caminos J.E., Seoane L.M., Tovar S.A., Casanueva F.F., Dieguez C. Influence of thyroid status and growth hormone deficiency on ghrelin. Eur J Endocrinol 2002; 147: 159-163. (Pubitemid 34814753)
23. DelParigi A., Tschop M., Heiman M.L. et al. High circulating ghrelin: A potential cause for hyperphagia and obesity in Prader-Willi syndrome. J Clin Endocrinol Metab 2002; 87: 5461-5464. (Pubitemid 36034344)
24. Bellone S., Rapa A., Vivenza D. et al. Circulating ghrelin levels as a function of gender, pubertal status and adiposity in childhood. J Endocrinol Invest 2002; 25: RC 13-15.
25. Dalkjaer Riis A.L., Hansen T.K., Moller N., Weeke J., Jorgensen J.O.L. Hyperthyroidism is associated with suppressed circulating ghrelin levels. J Clin Endocrinol Metab 2003; 88: 853-857. (Pubitemid 36207833)
26. Bergmann T., Lohmann T., Wallaschofski H. Association between thyroid function and ghrelin or adiponectin levels. Exp Clin Endocrinol Diabetes 2003; 111: 395-396.
27. Morpurgo P.S., Cappiello V., Verga U. et al. Ghrelin in human medullary thyroid carcinomas. Clin Endocrinol 2005; 63: 437-441. (Pubitemid 41442338)
28. Rojdmark S., Calissendorf J., Danielsson O., Brismar K. Hunger-satiety signals in patients with Graves' thyrotoxicosis before, during, and after long-term pharmacological treatment. Endocrine 2005; 27: 55-61. (Pubitemid 41112864)
29. Gimenez-Palop O., Gimenez-Perez G., Mauricio D. et al. Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes. Eur J Endocrinol 2005; 153: 73-79. (Pubitemid 41030518)
30. Altinova A.E., Toruner F.B., Akturk M. et al. Reduced serum acylated ghrelin levels in patients with hyperthyroidism. Horm Res 2006; 65: 295-299. (Pubitemid 43876733)
31. Altinova A.E. Serum ghrelin levels in patients with Hashimoto's thyroiditis. Thyroid 2006; 16: 1259-1264. (Pubitemid 46080170)
32. Gjedde S., Vestergaard E.T., Gormsen LCh et al. Serum ghrelin levels are increased in hypothyroid patients and become normalized by L-Thyroxine treatment. J Clin Endocrin Metab 2008; 93: 2277-2280. (Pubitemid 351831547)
33. Xin X., Ren A.J., Zheng X., Qin Y.W., Zhao X.X., Yuan W.J., Guo Z.F. Disturbance of circulating ghrelin and obestatin in chronic heart failure patients especially in those with cachexia. Peptides 2009; 30: 2281-2285.
34. Tanaka M., Naruo T., Muranaga T. et al. Increased casting plasma ghrelin levels in patients with bulimia nervosa. Eur J Endocrinol 2002; 146: R1-R3. (Pubitemid 34705084)
35. Malendowicz W., Ziółkowska A., Szyszka M., Kwias Z. Elevated blood active ghrelin and unaltered total ghrelin and obestatin concentration in prostate carcinoma. Urol Int 2009; 83: 471-475.
36. Braclik M., Marcisz C., Giebel S., Orzeł A. Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction. Thyroid 2008; 18: 545-550. (Pubitemid 351667831)
37. Patterson M., Murphy K.G., le Roux C.W., Ghatei M.A., Bloom S.R. Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab 2005; 90: 2205-2211. (Pubitemid 40586263)
38. Groschl M., Uhr M., Kraus T. Evaluation of the comparability of commercial ghrelin assays. Clin Chem 2004; 50: 457-458. (Pubitemid 38156396)